ChartInsight

Regeneron Pharmaceuticals Inc Financials

Revenue:
Net income:
Diluted EPS:

All values below without a dollar sign ($) are in millions (1,000,000) except for Earnings Per Share. Sourced from Regeneron Pharmaceuticals Inc SEC filings. All data provided as-is without any warranty. Check original SEC filings before making any investment decision.

Income Statement

Quarter EndingRevenue, NetSelling, General and Administrative ExpenseResearch and Development ExpenseOperating Income (Loss)Nonoperating Income (Expense)Net Income (Loss) Attributable to ParentEarnings Per Share, DilutedEarnings Per Share, BasicWeighted Average Number of Shares Outstanding, BasicWeighted Average Number of Shares Outstanding, Diluted
2018 Jun 365529622345514.825.12108114
2018 Mar1,511331499567184784.164.44108115
2017 Dec1,582410528539161741.51.62106116
2017 Sep1,50130753056063883.323.64107117
2017 Jun1,470307510550-243883.343.66106116
2017 Mar1,31929750743122492.162.36106115
2016 Dec1,227326479347-52532.192.41105116
2016 Sep1,22027054336332652.272.53105116
2016 Jun1,21329256029211961.691.88105116
2016 Mar1,20129047032911661.451.59104114
2015 Dec1,098295461231-41551.341.49103115
2015 Sep1,13721042639212101.822.04103116
2015 Jun999175390345-171951.691.89103115
2015 Mar870159343284-7760.660.74102115
2014 Dec802175352216-261100.961.09101113
2014 Sep726150338183-7800.70.79101117
2014 Jun666102295222-19930.820.92100113
2014 Mar626109287186-11650.580.6699112
2013 Dec61082268212-14970.860.9898111
2013 Sep59798224237-111411.251.4498117
2013 Jun45872187158-10870.790.8998111
2013 Mar44077180153-11990.91.0297109
2012 Dec41558181146-114704.084.9295115
2012 Sep42847158202-111911.722.0295116
2012 Jun3044814787-11770.70.8195110
2012 Mar2325813922-11120.110.1293108
2011 Dec12336129-45-9-53-0.59-0.599191
2011 Sep10333128-58-3-62-0.68-0.689191
2011 Jun10825143-60-3-63-0.69-0.699090
2011 Mar11223129-41-3-43-0.49-0.498989
2010 Dec13421125-13-2-15  8383
2010 Sep10616122-32-2-34    
2010 Jun11615125-24-2-25    
2010 Mar10414117-29-2-31    

Cash Flow

Quarter EndingPayments Related to Tax Withholding for Share-based CompensationNet Cash Provided by (Used in) Operating ActivitiesNet Cash Provided by (Used in) Investing ActivitiesNet Cash Provided by (Used in) Financing ActivitiesIncrease (Decrease) in InventoriesIncrease (Decrease) in Deferred RevenueIncrease (Decrease) in Accounts ReceivableIncome Tax Expense (Benefit)Depreciation, Depletion and AmortizationCash and Cash Equivalents, Period Increase (Decrease)
2018 Jun       105  
2018 Mar 619-4251389-55-3010736207
2017 Dec302951-865-85244-125225381107 
2017 Sep       177  
2017 Jun       138  
2017 Mar0356-14061701213818338277
2016 Dec1421,444-1,003-51088153-2547382 
2016 Sep       101  
2016 Jun       96  
2016 Mar129-44-191629139716423-205
2015 Dec1391,418-778-3391066251707259 
2015 Sep       183  
2015 Jun       133  
2015 Mar21-88-129766-1632120116-141
2014 Dec204690-185-31845-18-3010041 
2014 Sep       96  
2014 Jun       110  
2014 Mar6354-23610916379311012-74
2013 Dec192497-2086630-228910132 
2013 Sep       84  
2013 Jun       60  
2013 Mar386-1481218-6110439-50
2012 Dec11412-97-80 -32455-33629 
2012 Sep          
2012 Jun       0  
2012 Mar49-8716-18 -9135 8-89
2011 Dec24-131108371 -3026-124 
2011 Sep       1  
2011 Jun       -1  
2011 Mar1-112013 -10-50723
2010 Dec 106-298187 15521016 
2010 Sep       0  
2010 Jun       0  
2010 Mar -10-13656 4604-90

Assets

Quarter EndingCash and Cash Equivalents, at Carrying ValueAvailable-for-sale SecuritiesAccounts Receivable, Net, CurrentInventory, NetAssets, CurrentProperty, Plant and Equipment, NetDeferred Revenue, NoncurrentDeferred Revenue, CurrentAssets
2018 Jun918 1,5349294,8152,462  9,952
2018 Mar1,0192,3581,5328204,5452,3952581609,373
2017 Dec8132,0831,5397264,3352,3596293208,764
2017 Sep7921,9141,5336424,1362,2752751338,701
2017 Jun7441,5881,4205543,8602,2622961288,106
2017 Mar8121,4631,3404673,6692,2773161267,817
2016 Dec5351,3681,3433993,1802,0838312326,973
2016 Sep9201,2661,3323463,5021,8723281386,828
2016 Jun6479891,4323163,2091,773146846,205
2016 Mar6048001,4513033,1331,666171745,904
2015 Dec8098681,1522392,9151,5946651535,609
2015 Sep6559221,0881912,6761,47579545,183
2015 Jun391 1,0721712,2831,32677524,527
2015 Mar5087181,0161342,3111,111114524,199
2014 Dec6497127391292,167974176743,872
2014 Sep6478496741202,201819114583,739
2014 Jun6007686641101,919707128543,456
2014 Mar462721802871,871601129533,260
2013 Dec536548787701,797527184472,951
2013 Sep263 856631,634454112352,640
2013 Jun382 768571,561420120342,378
2013 Mar180 704441,307392125342,276
2012 Dec230355593291,206380208512,080
2012 Sep119 50730949373141331,661
2012 Jun172 35011769372  1,458
2012 Mar395 1596697370  1,350
2011 Dec484 284653368249521,324
2011 Sep206 4 34036416734983
2011 Jun254 3 413362175341,047
2011 Mar135 4 326357183331,074
2010 Dec113 14 358347189351,089
2010 Sep325 3 57631819739942
2010 Jun112 4 4182924242791
2010 Mar117        

© ChartInsight 2018, Seattle, WA